Literature DB >> 16873672

Enhanced VWF biosynthesis and elevated plasma VWF due to a natural variant in the murine Vwf gene.

Heidi L Lemmerhirt1, Jordan A Shavit, Gallia G Levy, Suzanne M Cole, Jeffrey C Long, David Ginsburg.   

Abstract

Both genetic and environmental influences contribute to the wide variation in plasma von Willebrand factor (VWF) levels observed in humans. Inbred mouse strains also have highly variable plasma VWF levels, providing a convenient model in which to study genetic modifiers of VWF. Previously, we identified a major modifier of VWF levels in the mouse (Mvwf1) as a regulatory mutation in murine Galgt2. We now report the identification of an additional murine VWF modifier (Mvwf2). Mvwf2 accounts for approximately 16% of the 8-fold plasma VWF variation (or approximately 25% of the genetic variation) observed between the A/J and CASA/RkJ strains and maps to the murine Vwf gene itself. Twenty SNPs were identified within the coding regions of the A/J and CASA/RkJ Vwf alleles, and in vitro analysis of recombinant VWF demonstrated that a single SNP (+7970G>A) and the associated nonsynonymous amino acid change (R2657Q) confers a significant increase in VWF biosynthesis from the CASA/RkJ Vwf allele. This change appears to represent a unique gain of function that likely explains the mechanism of Mvwf2 in vivo. The identification of a natural Vwf gene variant among inbred mice affecting biosynthesis suggests that similar genetic variation may contribute to the wide range of VWF levels observed in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873672      PMCID: PMC1895519          DOI: 10.1182/blood-2006-04-014688

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  The mosaic structure of variation in the laboratory mouse genome.

Authors:  Claire M Wade; Edward J Kulbokas; Andrew W Kirby; Michael C Zody; James C Mullikin; Eric S Lander; Kerstin Lindblad-Toh; Mark J Daly
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

2.  Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study.

Authors:  P D James; A D Paterson; C Notley; C Cameron; C Hegadorn; S Tinlin; C Brown; L O'Brien; J Leggo; D Lillicrap
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

Review 3.  Von Willebrand disease type 1: a diagnosis in search of a disease.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2002-10-31       Impact factor: 22.113

4.  A standard nomenclature for von Willebrand factor gene mutations and polymorphisms. On behalf of the ISTH SSC Subcommittee on von Willebrand factor.

Authors:  A C Goodeve; J C Eikenboom; D Ginsburg; L Hilbert; C Mazurier; I R Peake; J E Sadler; F Rodeghiero
Journal:  Thromb Haemost       Date:  2001-05       Impact factor: 5.249

5.  The genetics of haemostasis: a twin study.

Authors:  M de Lange; H Snieder; R A Ariëns; T D Spector; P J Grant
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

Review 6.  Modifier genes in mice and humans.

Authors:  J H Nadeau
Journal:  Nat Rev Genet       Date:  2001-03       Impact factor: 53.242

7.  Characterization of the mouse von Willebrand factor promoter.

Authors:  J Guan; P V Guillot; W C Aird
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

Review 8.  Getting at the variable expressivity of von Willebrand disease.

Authors:  G Levy; D Ginsburg
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

9.  Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6).

Authors:  Jennifer A Kearney; David A Buchner; Georgius De Haan; Maja Adamska; Stephen I Levin; Amy R Furay; Roger L Albin; Julie M Jones; Mauricio Montal; Martin J Stevens; Leslie K Sprunger; Miriam H Meisler
Journal:  Hum Mol Genet       Date:  2002-10-15       Impact factor: 6.150

10.  A single nucleotide polymorphism at nucleotide -1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels.

Authors:  P J Harvey; A M Keightley; Y M Lam; C Cameron; D Lillicrap
Journal:  Br J Haematol       Date:  2000-05       Impact factor: 6.998

View more
  12 in total

1.  A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice.

Authors:  Andrew Yee; Robert D Gildersleeve; Shufang Gu; Colin A Kretz; Beth M McGee; Keisha M Carr; Steven W Pipe; David Ginsburg
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

2.  Functional Consequences of Mannose and Asialoglycoprotein Receptor Ablation.

Authors:  Yiling Mi; Marcy Coonce; Dorothy Fiete; Lindsay Steirer; Gabriela Dveksler; R Reid Townsend; Jacques U Baenziger
Journal:  J Biol Chem       Date:  2016-07-12       Impact factor: 5.157

3.  Modeling Disorders of Blood Coagulation in the Zebrafish.

Authors:  Colin A Kretz; Angela C Weyand; Jordan A Shavit
Journal:  Curr Pathobiol Rep       Date:  2015-06

4.  von Willebrand factor propeptide to antigen ratio identifies platelet activation and reduced von Willebrand factor survival phenotype in mice.

Authors:  P M Jacobi; S Kanaji; D Jakab; A L Gehrand; J M Johnsen; S L Haberichter
Journal:  J Thromb Haemost       Date:  2018-01-24       Impact factor: 5.824

5.  The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance.

Authors:  Ahmad H Mufti; Kenichi Ogiwara; Laura L Swystun; Jeroen C J Eikenboom; Ulrich Budde; Wilma M Hopman; Christer Halldén; Jenny Goudemand; Ian R Peake; Anne C Goodeve; David Lillicrap; Daniel J Hampshire
Journal:  Blood Adv       Date:  2018-07-10

6.  Genetic regulation of plasma von Willebrand factor levels: quantitative trait loci analysis in a mouse model.

Authors:  H L Lemmerhirt; K W Broman; J A Shavit; D Ginsburg
Journal:  J Thromb Haemost       Date:  2006-11-28       Impact factor: 5.824

7.  Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.

Authors:  E Berntorp; B Fuchs; M Makris; R Montgomery; V Flood; J S O'Donnell; A B Federici; D Lillicrap; P James; U Budde; M Morfini; P Petrini; S Austin; C Kannicht; V Jiménez-Yuste; C Lee
Journal:  Haemophilia       Date:  2013-03       Impact factor: 4.287

8.  Selection on cis-regulatory variation at B4galnt2 and its influence on von Willebrand factor in house mice.

Authors:  Jill M Johnsen; Meike Teschke; Pavlos Pavlidis; Beth M McGee; Diethard Tautz; David Ginsburg; John F Baines
Journal:  Mol Biol Evol       Date:  2008-12-16       Impact factor: 16.240

9.  Modifiers of von Willebrand factor identified by natural variation in inbred strains of mice.

Authors:  Jordan A Shavit; Ani Manichaikul; Heidi L Lemmerhirt; Karl W Broman; David Ginsburg
Journal:  Blood       Date:  2009-09-29       Impact factor: 22.113

10.  An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS13 variant proteins that are less effective in cleaving von Willebrand factor multimers.

Authors:  Wenhua Zhou; Eric E Bouhassira; Han-Mou Tsai
Journal:  Blood       Date:  2007-04-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.